Zhende Medical Co., Ltd. (SHA:603301)
China flag China · Delayed Price · Currency is CNY
82.00
-1.00 (-1.20%)
Nov 17, 2026, 3:00 PM CST

Zhende Medical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
294.8260.82385.17198.4679.88595.86
Depreciation & Amortization
292.65292.65246.52242.97194.28139.3
Other Amortization
6.186.181.271.331.053.76
Loss (Gain) From Sale of Assets
-0.64-0.64-93.4315.9613.530.61
Asset Writedown & Restructuring Costs
-1.8-1.89.0954.328.883.31
Loss (Gain) From Sale of Investments
-10.78-10.78-7.37-12.4260.17-34.03
Provision & Write-off of Bad Debts
13.1113.1110.231.88.61.44
Other Operating Activities
-12.7879.8161.66214.65116.03198.18
Change in Accounts Receivable
-112.17-112.17-255.37307.45-127.9549.71
Change in Inventory
1.551.55-10.44-12.7-228.71279.07
Change in Accounts Payable
11.6311.63100.42-536.27507.89-426.96
Change in Other Net Operating Assets
---5.2217.3423.6
Operating Cash Flow
479.89538.49461.14452.111,246817.63
Operating Cash Flow Growth
-14.95%16.77%2.00%-63.72%52.40%-73.80%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-347.42-550.22-769.69-599.24-754.12-695.47
Sale of Property, Plant & Equipment
122.3467.53121.5912.619.586.78
Cash Acquisitions
--301.05-48.66-311.91-77.09-545.54
Divestitures
----51.57-
Investment in Securities
-74.91-20.2-74.85-159.25-216.68674.44
Other Investing Activities
8.136.313.62-0.07-6.055.36
Investing Cash Flow
-291.86-797.64-767.99-1,058-992.79-554.42

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---20.2841.55-
Long-Term Debt Issued
-1,6371,419916.91,839885
Total Debt Issued
1,1041,6371,419937.181,880885
Short-Term Debt Repaid
--15.69-28.35-16.38--
Long-Term Debt Repaid
--960.18-1,400-920.36-1,992-541.26
Lease Payments
-22.48-22.48-4.99-3.57-17.49-8.26
Total Debt Repaid
-1,141-975.87-1,428-936.74-1,992-541.26
Net Debt Issued (Repaid)
-37.98660.63-9.080.43-112.05343.74
Issuance of Common Stock
0.70.7--1,01852.5
Repurchase of Common Stock
-15.49-15.49---113.15-133.38
Common Dividends Paid
-110.29-201.49-159.4-423.72-164.25-543.65
Other Financing Activities
-80.77--0.95--172.96-98.77
Financing Cash Flow
-243.83444.34-169.43-423.28456-379.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-36.44-13.5421.212.81-3.7-38.29
Net Cash Flow
-92.25171.66-455.07-1,016705.55-154.65

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
132.47-11.73-308.55-147.13491.92122.16
Free Cash Flow Growth
----302.68%-93.98%
Free Cash Flow Margin
2.85%-0.27%-7.24%-3.56%8.02%2.40%
Free Cash Flow Per Share
0.51-0.04-1.16-0.552.080.54
Levered Free Cash Flow
20.265.1-532.76-338.45226.69-336.72
Unlevered Free Cash Flow
37.8584.78-514.8-320.37247.65-321.05
Free Cash Flow After Leases
109.99-34.21-313.54-150.7474.44113.9

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
69.63165.9176.7164.5838.26475.64
Change in Working Capital
-100.86-100.86-152-264.91163.63-90.81